- A Phased Approach for preparation and organization of human biomonitoring studies
Ulrike Fiddicke, L. Kim Pack, Hanna Tolonen, Ovnair Sepai, Marta Esteban López, Argelia Castaño, Greet Schoeters, Marike Kolossa-Gehring 12/2020
- Bisphenol A and its analogues: A comprehensive review to identify and prioritize effect biomarkers for human biomonitoring
Vicente Mustieles, Shereen Cynthia D'Cruz, Stephan Couderq, Andrea Rodríguez-Carrillo, Jean-Baptiste Fini, Tim Hofer, Inger-Lise Steffensen, Hubert Dirven, Robert Barouki, Nicolás Olea, Mariana F. Fernández, Arthur David 08/2020
- Receptor-based in vitro activities to assess human exposure to chemical mixtures and related health impacts
Anne Marie Vinggaard, Eva Cecilie Bonefeld-Jørgensen, Tina Kold Jensen, Mariana F. Fernandez, Anna Kjerstine Rosenmai, Camilla Taxvig, Andrea Rodriguez-Carrillo, Maria Wielsøe, Manhai Long, Nicolas Olea, Jean-Philippe Antignac, Timo Hamers, Marja Lamoree 10/2020
- Assessment of perfluoroalkyl substances in placenta by coupling salt assisted liquid-liquid extraction with dispersive liquid-liquid microextraction prior to liquid chromatography-tandem mass spectrometry
F.Vela-Soria, J.García-Villanova, V.Mustieles, T.de Haro, J.P.Antignac, M.F.Fernandez 08/2020
- Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment
Petra Apel, Christophe Rousselle, Rosa Lange, Fatoumata Sissoko, Marike Kolossa-Gehring, Eva Ougier
09/2020
- Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review
Sophie A. H. Boesen, Manhai Long, Maria Wielsøe, Vicente Mustieles, Mariana F. Fernandez, Eva C. Bonefeld-Jørgensen 10/2020
- Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU
Madlen David, Gerda Schwedler, Lena Reiber, Hanna Tolonen, Anna-Maria Andersson, Marta Esteban López, Anke Joas, Miriam Schöpel, Alexandra Polcher, Marike Kolossa-Gehring 09/2020
- Testing for thyroid hormone disruptors, a review of non-mammalian in vivo models
Stephan Couderq, Michelle Leemans, Jean-Baptiste Fini 03/2020
- Pesticides with potential Thyroid Hormone-Disrupting Effects: A review of recent data
Michelle Leemans, Stephan Couderq, Barbara Demeneix and Jean-Baptiste Fini 12/2019
- Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells
Katrin Kreuzer, Linda Böhmert, Deema Alhalabi, Thorsten Buhrke, Alfonso Lampen, Albert Braeuning 03/2020
- Transcriptomic effect marker patterns of genotoxins – a comparative study with literature data
Katrin Kreuzer, Falko Frenzel, Alfonso Lampen, Albert Braeuning, Linda Böhmert 12/2019
- Bisphenols and oxidative stress biomarkers – Associations found in human studies, evaluation of methods used, and strengths and weaknesses of the biomarkers
Inger-Lise Steffensen, Hubert Dirven, Stephan Couderq, Arthur David, Shereen Cynthia D'Cruz, Mariana F. Fernández, Vicente Mustieles, Andrea Rodríguez-Carillo, Tim Hofer 05/2020
- Towards Harmonized Biobanking for Biomonitoring: A Comparison of Human Biomonitoring-Related and Clinical Biorepositories
Dominik Lermen, Frederik Gwinner, Martina Bartel-Steinbach, Sabine C. Mueller, Jens K. Habermann, Matharoo-Ball Balwir, Elke Smits, Ana Virgolino, Ulrike Fiddicke, Marika Berglund, Agneta Åkesson, Anna Bergstrom, Karin Leander, Milena Horvat, Janja Snoj Tratnik, Manuel Posada de la Paz, Argelia Castaño Calvo, Marta Esteban López, Hagen von Briesen, Heiko Zimmermann and Marike Kolossa-Gehring
04/2020
- Biomonitoring for occupational exposure to diisocyanates: a systematic review
Bernice Scholten, Laura Kenny, Radu-Corneliu Duca, Anjoeka Pronk, Tiina Santonen, Karen S Galea, Miranda Loh, Katriina Huumonen, Anne Sleeuwenhoek, Matteo Creta, Lode Godderis, Kate Jones
04/2020
- Suspect and non-targeted screening of chemicals of emerging concern for human biomonitoring, environmental health studies and support to risk assessment: From promises to challenges and harmonisation issues
Marianne Pourchet, Laurent Debrauwer, Jana Klanova, Elliott J. Price, Adrian Covaci, Noelia Caballero-Casero, Herbert Oberacher, Marja Lamoree, Annelaure Damont, François Fenaille, Jelle Vlaanderen, Jeroen Meijer, Martin Krauss, Denis Sarigiannis, Robert Barouki, Bruno Le Bizec, Jean-Philippe Antignac
04/2020
- Relying on repeated biospecimens to reduce the effects of classical-type exposure measurement error in studies linking the exposome to health
Lydiane Agier, Rémy Slama, Xavier Basagaña
04/2020
- Comparison of polycyclic aromatic hydrocarbon metabolite concentrations in urine of mothers and their newborns
Katerina Urbancova, Darina Dvorakova, Tomas Gramblicka, Radim J. Sram, Jana Hajslova, Jana Pulkrabova
03/2020
- Dietary intake of acrylamide and risk of breast, endometrial and ovarian cancers: A systematic review and dose-response meta-analysis
Giorgia Adani, Tommaso Filippini, Lauren A Wise, Thorhallur I Halldorsson, Ludek Blaha and Marco Vinceti
03/2020
- A European proposal for quality control and quality assurance of tandem mass spectral libraries
Herbert Oberacher, Michael Sasse, Jean-Philippe Antignac, Yann Guitton, Laurent Debrauwer, Emilien L. Jamin, Tobias Schulze, Martin Krauss, Adrian Covaci, Noelia Caballero-Casero, Kathleen Rousseau, Annelaure Damont, François Fenaille, Marja Lamoree, Emma L. Schymanski
03/2020
- Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium
Tiina Santonen, Alessandro Alimonti, Beatrice Bocca, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Thomas Göen, Bruno Gomes. Ogier Hanser, Ivo Iavicoli, Beata Janasik, Kate Jones, Mirja Kiilunen, Holger M. Koch, Elizabeth Leese, Veruscka Leso, Henriqueta Louro, Sophie Ndaw, Simo P. Porras, Alain Robert, Flavia Ruggieri, Paul T.J. Scheepers, Maria J.Silva, Susana Viegas, Wojciech Wasowicz, Argelia Castano, Ovnair Sepai
07/2019
- A review of phthalate pharmacokinetics in human and rat: what factors drive phthalate distribution and partitioning?
Elena Domínguez-Romero, Martin Scheringer
06/2019
- Linking past uses of legacy SVOCs with today's indoor levels and human exposure
Hale Demirtepe, Lisa Melymuk, Miriam L. Diamond, Lola Bajard, Šimon Vojta, Roman Prokeš, Ondřej Sáňka, Jana Klánová, Ľubica Palkovičová Murínová, Denisa Richterová, Vladimíra Rašplová, Tomáš Trnovec
04/2019
- Annotating Non-targeted LC-MS/MS Data with Two Complementary Tandem Mass Spectral Libraries
Herbert Oberacher, Vera Reinstadler, Marco Kreidl, Michael A. Stravs, Juliane Hollender and Emma L. Schymanski 12/2018
- Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment
Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, Thomas Backhause, Tina Bahadori, Robert Barouki, Werner Brack, Mark T.D. Cronin, Barbara Demeneix, Susanne HougaarD Bennekou, Jacobvan Klaveren, Carsten Kneuer, Marike Kolossa-Gehring, Erik Lebret, Leo Posthuma, Lena Reiber, Cynthia Rider, Joëlle Rüegg, Giuseppe Testa, Bart van der Burg, Hilkovan der Voet, A. Michael Warhurst, Bob van de Water, Kunihiko Yamazaki, Mattias Öberg, Åke Bergman 11/2019
- Deciphering adverse outcome pathway network linked to Bisphenol F using text mining and systems toxicology approaches
Marylène Rugard, Xavier Coumoul, Jean-Charles Carvaillo, Robert Barouki, Karine Audouze 10/2019
- Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study
Loreta Strumylaite, Rima Kregzdyte, Algirdas Bogusevicius, Lina Poskiene, Dale Baranauskiene and Darius Pranys 06/2019
- A strategy to validate a selection of human effect biomarkers using adverseoutcome pathways: Proof of concept for phthalates and reproductive effects
Kirsten Baken, Nathalie Lambrechts, Greet Schoeters, et al. 05/2019
- Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future
Henriqueta Louro, Tiina Santonen, et al. 05/2019
- Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach
Jean-Charles Carvaillo, Robert Barouki, Xavier Coumoul and Karine Audouze 04/2019
- Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways
Lola Bajard, Lisa Melymuk and Ludek Blaha 02/2019
- Physiology-based toxicokinetic modeling in the frame of the European Human Biomonitoring Initiative
Sarigiannis, D.A., Karakitsios, S., Dominguez-Romero, E., Papadaki, K., Brochot, C., Kumar, V., Schumacher, M., Sy, M., Mielke, H., Greiner, M., Mengelers, M., Scheringer, M. 01/2019
- Current EU research activities on combined exposure to multiple chemicals
Stephanie K. Bopp et. al, 08/2018
- Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population
Jurgen Buekers et. al 09/2018
- Human biomonitoring as a tool to support chemicals regulation in the European Union
Catherine Ganzleben et. al, 01/2017
- Special Issue „Human Biomonitoring 2016“
Gerda Schwedler et. al 03/2017
- Human biomonitoring in Israel: Recent results and lessons learned
Tamar Bermana et. al, 12/2017
- Towards a systematic use of effect biomarkers in population and occupational biomonitoring
Maryam Zare Jeddi, Nancy B.Hopf, Susana Viegas, Anna Bal Price, Alicia Paini, Christoph van Thriel, Emilio Benfenati, Sophie Ndaw, Jos Bessems, Peter A. Behnisch, Gabriele Leng, Radu-Corneliu Duca, Hans Verhagen, Francesco Cubadda, Lorraine Brennan, Imran Ali, Arthur David, Vicente Mustieles, Mariana F. Fernandez, Henriqueta Louro, Robert Pasanen-Kase 12/2020
- Bisphenol A shapes children's brain and behavior: towards an integrated neurotoxicity assessment including human data
Vicente Mustieles, Mariana F. Fernández 06/2020
- Deliverable 8.1 Description of the national programmes - a strategy to collect EU wide HBM data
Greet Schoeters (VITO) et al. 04/2018
- Deliverable 7.3 1st prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling
Ulrike Fiddicke (UBA) et. al, 02/2018
- Deliverable 5.2 1st substance-group specific derivation of EU-wide health-based guidance values
Petra Apel (UBA) et. al, 12/2017
- Additional Deliverable AD 8.2 Research plan for chromates study under HBM4EU
Sophie Ndaw (INRS) et. al, 01/2018
- Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands
Dominik Lermen (IBMT) et. al, 12/2017
- Deliverable 7.1 Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM
Ana Virgolino (FMUL) et. al, 12/2017
- Deliverable 10.2 Statistical Analysis Plan
Martine Vrijheid (ISGlobal) et. al, 12/2017
- Deliverable 5.3 Scoping paper on the development of an indicator on chemical exposure in the European population
Xenia Trier (EEA) et. al, 12/2017
- Deliverable 12.2 Report on the optimal methodology for exposure reconstruction from HBM data
Milena Horvat (JSI) et. al, 12/2017
- Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances
Marja Lamoree (VU-IVM) et. al, 12/2017
- Additional Deliverable 16.1 Screening methods inventory
Mariane Pourchet-Gellez (INRA) et. al, 12/2017
- Deliverable 16.1 Prioritised list of known emerging chemicals
Jelle Vlaanderen (IRAS) et. al, 12/2017
- Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan
Jelle Vlaanderen (IRAS) et. al, 12/2017
- Additional Deliverable 5.1 A (phased) plan for action: how structurered multi-actor dialogues on human biomonitoring results can facilitate targeted policy action (generic canvas for HBM4EU)
Ann Crabbé (UAntwerpen) et. al, 12/2017
- Deliverable 2.4 2018 Programme of training activities, materials and capacity building mechanisms
Paul T.J. Scheepers (RUMC) et. al, 12/2017
- Deliverable 5.1 Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals
Tiina Santonen (FIOH) et. al, 11/2017
- Deliverable 9.4 The Quality Assurance/Quality Control Scheme in the HBM4EU project
Thomas Göen (IPASUM) et. al, 11/2017
- Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU?
Madlen David (UBA) et. al, 10/2017
- Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances
Alberto Gotti (IUSS) et. al, 10/2017
- Deliverable 9.3 Database of candidate laboratories for the 1st prioritisation round of substances
Octavio Pérez Luzardo (ULPGC) et. al, 10/2017
- Deliverable 2.3 2018 Strategy for the communication and dissemination of HBM4EU results
Catherine Ganzleben (EEA) et. al, 10/2017
- Deliverable 14.1 Criteria for prioritisation of biomarkers of effect
Nicolás Olea (UGR) et. al, 10/2017
- Additional Deliverable 11.2 Criteria for feasibility studies
Hanna Tolonen (THL) et. al, 09/2017
- Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board
Lena Reiber (UBA) et. al, 09/2017
- Deliverable 9.2 Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritisation round of substances
Cathrine Thomsen (NIPH) et. al, 09/2017
- Deliverable 4.3 Prioritisation strategy and criteria
Jean-Nicholas Ormsby (ANSES) et. al, 08/2017
- Additional Deliverable 12.2 Roadmap for model PBTK/D model refinement and analysis for priority substances
Laurent Bodin (ANSES) et. al, 08/2017
- Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances
Alberto GOTTI et. al, 07/2017
- Deliverable 10.1 Data Management Plan, July 2017
Sylvie Remy (VITO) et. al,
07/2017
- Annex to Deliverable 10.1 Data Policy, July 2017
Sylvie Remy (VITO) et. al, 07/2017
- Additional deliverable 8.1 Report on access to occupational data
Tiina Santonen (FIOH) et. al, 06/2017
- Deliverable 13.1 Criteria for the selection of cohort studies, June 2017
Thorhallur Ingi Halldorsson (UI) et. al, 06/2017
- Deliverable 6.1 First set of key indicators for HBM4EU, June 2017
Hans Reynders et. al,
06/2017
- Deliverable 4.2 Scoping documents on HBM4EU priority substances for 2018, June 2017
Greet Schoeters (VITO) et. al, 06/2017
- Deliverable 4.1 Template for the submission of rapid requests, May 2017
Jean-Nicolas Ormsby (ANSES) et. al, 05/2017
- Deliverable 9.1 Criteria for the prioritisation of biomarkers, April 2017
Loïc Rambaud (ANSP) et. al, 04/2017
- Deliverable 2.1 HBM4EU Website, March 2017
Catherine Ganzleben and Derya Ay (EEA) 03/2017
- Deliverable 2.2 Strategy for the communication and disseminatoin of HBM4EU results, March 2017
Catherine Ganzleben (EEA) 03/2017
- Deliverable 1.2 Establishment of Governing Board, February 2017
Ulrike Doyle (UBA) et. al, 02/2017
- Grant Agreement, November 2016
Number: 733032 11/2016
- Deliverable 1.2 Establishment of the HBM4EU Governing Board
Ulrike Doyle (UBA) et. al, 03/2017
- Chemical mixtures pose ‘underestimated’ risk to human health say scientists
Marike Kolossa-Gehring 05/2019
- RECETOX Newsletter
Research Centre for Toxic Compounds in the Environment (RECETOX) 11/2018
- ECHA Newsletter 2017 - Issue 3
European Chemicals Agency
09/2017
- European Union research in support of environment and health: Building scientific evidence base for policy
Tuomo Karjalainen et. al, 04/2017
- Informationsplattform IPCheM: Zentraler Zugang zu Daten des Chemischen Monitorings in Europa
Gerlinde Knetsch and Maria Rüther, UMID 01/2017
- Workshop Report HBM4EU: Nordic workshop for scientists and regulatory agencies discussing HBM4EU - the European human biomonitoring initiative
Knudsen, Lisbeth E. and Hansen, Pernille Winton 08/2017
- Human biomonitoring: a cornerstone for environment and health policies
Maria João Silva 11/2016
- Human biomonitoring: Science and policy for a healthy future, April 17–19, 2016, Berlin, Germany
Anke Joas et. al, 03/2017
- Bringing together raptor collections in Europe for contaminant research and monitoring in relation to chemicals regulations
Paola Movalli et. al,
09/2017
- The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective
Fiona Sewell et. al, 08/2017
- Life cycle-based health risk assessment of plastic waste
D.A. Sarigiannis et. al, 12/2017
- Ikke-regulerede flammehæmmere i indeklimaet – nye eksponerings- og sundhedsrisici?
Katrin Vorkamp et. al, 12/2017
- Human Biomonitoring: Die Umwelt in unserem Koerper
Oekoskop 12/2017
- The added value of a surveillance human biomonitoring program: The case of FLEHS in Flanders (Belgium)
Hans Reynders et. al, 03/2017
- Human biomonitoring pilot study DEMOCOPHES in Germany: Contribution to a harmonized European approach
Gerda Schwedler et al. 06/2017
- Advancing environmental health surveillance in the US through a national human biomonitoring network
Megan Weil Latshaw et. al, 03/2017
- Guest blog from the European Environment Agency (EEA): Human Biomonitoring for Europe
Health and Environment Alliance 11/2017
